Infinity Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview

Infinity Pharmaceuticals

24/03/2023 11:24

* Infinity Pharmaceuticals Inc  INFI.OQ   INFI.O  is
expected
to show a rise in quarterly revenue when it reports  results on
March 27 (estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 33.0% increase in revenue to $600 thousand from $451 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Infinity
Pharmaceuticals
Inc is for a loss of 3 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $4​, above​ its last closing price
of $0.19. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.07       -0.06      -0.12     Missed  -100
 Jun. 30 2022  -0.15       -0.15      -0.13     Beat    11
 Mar. 31 2022  -0.13       -0.13      -0.14     Missed  -3.7​
 Dec. 31 2021  -0.14       -0.13      -0.13     Met     3.7
 ​​Sep.        -0.13       -0.13      -0.12     Beat    10.8
 30 2021                                                
 Jun. 30 2021  -0.14       -0.14      -0.13     Beat    4.4​
 Mar. 31 2021  -0.12       -0.12      -0.15     Missed  -20.2
 Dec. 31 2020  -0.16       -0.16      -0.16     Met     -2.1
 This summary was machine generated March 24 at 11:24 GMT.  All
figures in US dollars  unless otherwise stated